Latent tuberculosis and the use of immunomodulatory agents
AUTOR(ES)
Aguiar, Fábio Silva
FONTE
J. bras. pneumol.
DATA DE PUBLICAÇÃO
09/12/2019
RESUMO
Documentos Relacionados
- The use of Mycobacterium tuberculosis HspX and GlcB proteins to identify latent tuberculosis in rheumatoid arthritis patients
- Latent tuberculosis treatment
- Latent tuberculosis treatment
- Latent tuberculosis: the snake inside the egg
- Diagnosis and treatment of latent tuberculosis infection in patients undergoing treatment with immunobiologic agents: a four-year experience in an endemic area